TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
TBCRC 039:一项关于术前使用鲁索替尼联合或不联合紫杉醇治疗三阴性炎性乳腺癌的II期研究
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-024-01774-0
Lynce, Filipa; Stevens, Laura E; Li, Zheqi; Brock, Jane E; Gulvady, Anushree; Huang, Ying; Nakhlis, Faina; Patel, Ashka; Force, Jeremy M; Haddad, Tufia C; Ueno, Naoto; Stearns, Vered; Wolff, Antonio C; Clark, Amy S; Bellon, Jennifer R; Richardson, Edward T; Balko, Justin M; Krop, Ian E; Winer, Eric P; Lange, Paulina; Hwang, E Shelley; King, Tari A; Tolaney, Sara M; Thompson, Alastair; Gupta, Gaorav P; Mittendorf, Elizabeth A; Regan, Meredith M; Overmoyer, Beth; Polyak, Kornelia